| 29130109 | Deubiquitinase USP9X promotes cell migration, invasion and inhibits apoptosis of human pancreatic cancer. | Oncol Rep | 2017 Dec | Liu L | doi: 10.3892/or.2017.6050 |
| 23171055 | The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition. | BMC Cancer | 2012 Nov 21 | Peddaboina C | doi: 10.1186/1471-2407-12-541. |
| 25814533 | Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies. | Blood | 2015 Jun 4 | Peterson LF | doi: 10.1182/blood-2014-10-605584 |
| 24841553 | Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma. | Cancer Biol Ther | 2014 Aug | Cox JL | doi: 10.4161/cbt.29182 |
| 29183995 | Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway. | J Biol Chem | 2018 Jan 26 | Zhu C | doi: 10.1074/jbc.RA117.000392 |
| 27770309 | USP9X, a Putative Tumor Suppressor Gene, Exhibits Frameshift Mutations in Colorectal Cancers. | Pathol Oncol Res | 2017 Jan | Jo YS | doi: 10.1007/s12253-016-0140-z |
| 27374971 | Deubiquitylating enzyme, USP9X, regulates proliferation of cells of head and neck cancer lines. | Cell Prolif | 2016 Aug | Nanayakkara DM | doi: 10.1111/cpr.12273 |
| 22895071 | Genetic disruption of USP9X sensitizes colorectal cancer cells to 5-fluorouracil. | Cancer Biol Ther | 2012 Nov | Harris DR | doi: 10.4161/cbt.21792 |
| 25028367 | USP9X downregulation renders breast cancer cells resistant to tamoxifen. | Cancer Res | 2014 Jul 15 | Oosterkamp HM | doi: 10.1158/0008-5472.CAN-13-1960. |
| 26717875 | β-catenin is regulated by USP9x and mediates resistance to TRAIL-induced apoptosis in breast cancer. | Oncol Rep | 2016 Feb | Ouyang W | doi: 10.3892/or.2015.4463 |
| 22699621 | The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. | Nature | 2012 Apr 29 | P??rez-Mancera PA | doi: 10.1038/nature11114. |
| 25692226 | USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1. | Cancer Biol Ther | 2015 | Kushwaha D | doi: 10.1080/15384047.2014.1002358. |
| 27120977 | BAG3-mediated Mcl-1 stabilization contributes to drug resistance via interaction with USP9X in ovarian cancer. | Int J Oncol | 2016 Jul | Habata S | doi: 10.3892/ijo.2016.3494 |
| 27593927 | Cellular stress induces TRB3/USP9x-dependent Notch activation in cancer. | Oncogene | 2017 Feb 23 | Izrailit J | doi: 10.1038/onc.2016.276 |
| 28115363 | Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x-SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis. | Cancer Res | 2017 Mar 15 | Wu Y | doi: 10.1158/0008-5472.CAN-16-2012 |
| 28720576 | Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway. | Cancer Res | 2017 Sep 15 | Toloczko A | doi: 10.1158/0008-5472.CAN-16-3413 |
| 28274596 | Aberrant expression of deubiquitylating enzyme USP9X predicts poor prognosis in gastric cancer. | Clin Res Hepatol Gastroenterol | 2017 Dec | Fu X | doi: 10.1016/j.clinre.2017.01.008 |
| 29449692 | The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization. | Oncogene | 2018 May | Li L | doi: 10.1038/s41388-018-0134-2 |
| 30689267 | Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells. | Cancer Sci | 2019 Apr | Lu Q | doi: 10.1111/cas.13953 |
